DRUG · Mapped RxNorm record
Saxagliptin
Normalized identity: saxagliptinView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Effect of Saxagliptin on Pre-Diabetes Mellitus and Obesity
NCT01960205
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Mapped RxNorm record
saxagliptin
Normalized identity: saxagliptinView linked drug · Find medicine records ·
Find other trials using this name
DRUG · Mapped RxNorm record
metformin
Normalized identity: metforminView linked drug · Find medicine records ·
Find other trials using this name
OTHER · Unmapped registry intervention
lifestyle intervention
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedEffect of Saxagliptin on Pre-Diabetes Mellitus and Obesity
Design: INTERVENTIONAL · Status: UNKNOWN · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prediabetesverified · MONDO: prediabetes syndrome
Interventions
SaxagliptinDRUG · verified · RxNorm: saxagliptin
saxagliptinDRUG · verified · RxNorm: saxagliptin
metforminDRUG · verified · RxNorm: metformin
Sponsors & collaborators
Shandong Provincial Hospitallead sponsor
Chinese Medical Associationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01960205 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.